Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Tekmira Pharmaceuticals Company Profile (NASDAQ:TKMR)

Consensus Ratings for Tekmira Pharmaceuticals (NASDAQ:TKMR) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $28.90 (71.31% upside)

Analysts' Ratings History for Tekmira Pharmaceuticals (NASDAQ:TKMR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/6/2014Leerink SwannDowngradeOutperform -> Market Perform$25.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
10/3/2014Maxim GroupBoost Price TargetBuy$23.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Leerink SwannInitiated CoverageOutperform$25.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Maxim GroupReiterated RatingBuy -> Hold$23.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014Clarus SecuritiesInitiated CoverageBuy$22.50ViewTweet This Rating  Share This Rating on StockTwits
6/4/2014Maxim GroupLower Price TargetBuy$29.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Stifel NicolausReiterated RatingBuy$37.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
4/11/2014RBC CapitalInitiated CoverageOutperform$30.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Maxim GroupBoost Price TargetBuy$17.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Stifel NicolausInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013Maxim GroupBoost Price TargetBuy$9.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
9/24/2013Maxim GroupBoost Price TargetBuy$7.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2013Maxim GroupReiterated RatingBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/30/2012 forward)
Discuss Tekmira Pharmaceuticals